Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Mallinckrodt
Dow
Farmers Insurance
UBS
Merck
McKinsey
Teva
Cipla

Generated: June 25, 2018

DrugPatentWatch Database Preview

KEFLIN Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Keflin, and when can generic versions of Keflin launch?

Keflin is a drug marketed by Lilly and is included in two NDAs.

The generic ingredient in KEFLIN is cephalothin sodium. There are seven drug master file entries for this compound. Additional details are available on the cephalothin sodium profile page.
Summary for KEFLIN
Drug patent expirations by year for KEFLIN
Medical Subject Heading (MeSH) Categories for KEFLIN
Synonyms for KEFLIN
(6R,7R)-3-(acetoxymethyl)-8-keto-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-(Acetoxymethyl)-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2
(6R,7R)-3-(Acetoxymethyl)-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-(Acetoxymethyl)-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid
(6R,7R)-3-(acetoxymethyl)-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-(acetyloxymethyl)-8-oxidanylidene-7-(2-thiophen-2-ylethanoylamino)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(1-oxo-2-thiophen-2-ylethyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7-[2-(thiophen-2-yl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
153-61-7
153C617
2073-29-2
3-(Acetoxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
3-(Hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid acetate
3-Acetoxymethyl-7-(2-thienylacetamido)-3-cephem-4-carboxylic acid
3-acetoxymethyl-7beta-(2-thienylacetamido) ceph-3-em-4-carboxylic acid
3-acetoxymethyl-7beta-(2-thienylacetamido)-3-cephem-4-carboxylic acid
3-Acetoxymethyl-7beta-(2-thienylacetamido)ceph-3-em-4-carboxylic acid
3-ACETOXYMETHYL-8-OXO-7-(2-THIOPHEN-2-YL-ACETYLAMINO)-5-THIA-1-AZA-BICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLIC ACID
4kox
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-8-oxo-7-((2-thienylacetyl)amino)-, (6R-trans)-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-8-oxo-7-((2-thienylacetyl)amino)-, (6R,7R)-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-, acetate (ester)
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-8-oxo-7-[(2-thienylacetyl)amino]-, (6R,7R)-
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid, 3-[(acetyloxy)methyl]-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-, (6R,7R)-
58-71-9 (mono-hydrochloride salt)
6R-trans-3-((Acetyloxy)methyl)-8-oxo-7-((2-thienylacetyl)amino)-5-thia-1-azabicyclo(4.2.0)-oct-2-ene-2-carboxylic acid
7-(2-(2-Thienyl)acetylamido)cephalosporanic acid
7-(2-thienylacetamido) cephalosporanic acid
7-(2-thienylacetamido)-cephalosporanic acid
7-(2-THIENYLACETAMIDO)CEPHALOSPORANIC
7-(2-Thienylacetamido)cephalosporanic acid
7-(2'-thienylacetamido)cephalosporanic acid
7-(Thiophene-2-acetamido)cephalosporanic acid
7-(Thiophene-2-acetamido)cephalosporin
7beta-(thiophen-2-ylacetamido)-3-acetoxymethyl-3,4-didehydrocepham-4-carboxylic acid
AC1L1LMU
ACN-045431
AJ-45761
AK-72984
AKOS015920120
AN-8313
Averon-1
BDBM82898
Bio-0631
BPBio1_001031
BR-72984
BRD-K28210218-236-05-7
BRN 0945586
BSPBio_000937
BSPBio_001963
C07761
C16H16N2O6S2
CAS-153-61-7
Cefalothin
Cefalotin
Cefalotin (BAN)
Cefalotin [INN]
cefalotin sodium
Cefalotina
Cefalotina [INN-Spanish]
Cefalotina fabra
Cefalotina fabra (TN)
Cefalotine
Cefalotine [INN-French]
Cefalotinum
Cefalotinum [INN-Latin]
Cemastin
cephalothin
Cephalothin Monosodium Salt
Cephalothin, Antibiotic for Culture Media Use Only
Cephalothinum
Cephalotin
CHEBI:124991
CHEMBL617
cid_6024
Coaxin
CS-W008776
CTK0I1695
D01PLN
D07635
DB00456
DivK1c_000097
DSSTox_CID_2783
DSSTox_GSID_22783
DSSTox_RID_76728
DTXSID4022783
EINECS 205-815-7
Epitope ID:116207
FT-0653512
GS-3577
GTPL8798
HE344988
HMS2267P23
HSDB 3024
IDI1_000097
KB-209050
KBio1_000097
KBio2_000550
KBio2_003118
KBio2_005686
KBio3_001183
KBioGR_000738
KBioSS_000550
Keflin (TN)
Lopac0_000283
LS-150069
MFCD00242614
MLS001048966
MolPort-002-515-763
NCGC00023699-09
NCGC00159332-02
NINDS_000097
Prestwick0_000719
Prestwick1_000719
Prestwick2_000719
Prestwick3_000719
R72LW146E6
S-1796
SBI-0050271.P004
SC-18881
SCHEMBL2990
Seffin
SMR000386987
SPBio_000162
SPBio_002858
Spectrum_000110
Spectrum2_000121
Spectrum3_000332
Spectrum4_000269
Spectrum5_000669
ST2408077
Tox21_111579
Tox21_111579_1
UNII-R72LW146E6
XIURVHNZVLADCM-IUODEOHRSA-N
Z1741977144
ZINC3830507

US Patents and Regulatory Information for KEFLIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly KEFLIN cephalothin sodium INJECTABLE;INJECTION 050482-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lilly KEFLIN cephalothin sodium INJECTABLE;INJECTION 050482-007 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lilly KEFLIN cephalothin sodium INJECTABLE;INJECTION 050482-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lilly KEFLIN cephalothin sodium INJECTABLE;INJECTION 050482-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Express Scripts
Cipla
Baxter
Teva
AstraZeneca
Farmers Insurance
Cerilliant
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.